Webinar | TiO₂ alternatives for food, pharma, and personal care Register Here

GLX Analytix

At GLX Analytix, we combine a new, proprietary class of blood biomarker with AI to bring personalized medicine to your healthcare.
2019
2-10
Copenhagen, Hovedstaden, Denmark
BiotechnologynologyHealth CareMedicalPrecision Medicine

Investment Funding

Last Funding Stage

Venture - Series Unknown

Last Funding Date

29-10-2024

Lead Investors

Vaekstfonden, DigitalDx Ventures, Alzheimer's Drug Discovery Foundation, LabCorp Venture Fund, CBC Investment Group

Revenue

Less than $1M

People

Founders